therapeutic endoscopic surgery: Clinical Trials

3 trials of therapeutic endoscopic surgery, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 1 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 11Completed 1
Phase 21Terminated 1

Follow therapeutic endoscopic surgery: new trials by email Literature Review of therapeutic endoscopic surgery trials Research Report on therapeutic endoscopic surgery

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Transoral Robotic Surgery or Standard Surgery in Treating Patients With Benign or Malignant Tumors of the Larynx and Pharynx
assessment of therapy complications, diagnostic endoscopic surgery, quality-of-life assessment - Head and Neck Cancer, Perioperative/Postoperative Complications
Phase 1CompletedBarbara Ann Karmanos Cancer Institute62009-05-012014-05-09
Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical Resection
erlotinib hydrochloride, therapeutic endoscopic surgery, laboratory biomarker analysis - Stage IA Non-small Cell Lung Cancer, Stage IB Non-small Cell Lung Cancer
Phase 2TerminatedNational Cancer Institute (NCI)1102004-12-012013-06-06
Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal Cancer
cisplatin, fluorouracil, questionnaire administration - Esophageal Cancer, Gastric Cancer
Not applicableCompletedNorth Wales Organisation for Randomised Trials in Health7002004-09-012013-08-07

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Esophageal Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Postoperative Complications (1)  ·  Precancerous Conditions (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Stomach Neoplasms (1)

Sponsors

Barbara Ann Karmanos Cancer Institute (1)  ·  National Cancer Institute (NCI) (1)  ·  North Wales Organisation for Randomised Trials in Health (1)

Countries

United States (2)  ·  United Kingdom (1)

Top investigators

Ho-Sheng Lin, MD (1)  ·  Ken Park, MD (1)  ·  Steven Keller (1)

NIH funding

P30CA022453 (1), U10CA021115 (1)